Suppr超能文献

趋化因子诱饵受体D6对CC趋化因子的识别与适应性上调及降解取决于其N端序列。

Recognition versus adaptive up-regulation and degradation of CC chemokines by the chemokine decoy receptor D6 are determined by their N-terminal sequence.

作者信息

Savino Benedetta, Borroni Elena Monica, Torres Nina Machado, Proost Paul, Struyf Sofie, Mortier Anneleen, Mantovani Alberto, Locati Massimo, Bonecchi Raffaella

机构信息

Department of Translational Medicine, University of Milan, 20089 Milan, Italy.

出版信息

J Biol Chem. 2009 Sep 18;284(38):26207-15. doi: 10.1074/jbc.M109.029249. Epub 2009 Jul 24.

Abstract

The chemokine decoy receptor D6 controls inflammatory responses by selective recognition and degradation of most CCR1 to CCR5 agonistic ligands. CCL14 is a homeostatic chemokine present at high concentrations in the serum with a weak agonist activity on CCR1. Under inflammatory conditions, plasmin and UPA-mediated truncation of 8 amino acids generates the potent CCR1/CCR3/CCR5 isoform CCL14(9-74), which is further processed and inactivated by dipeptidyl peptidase IV/CD26 that generates CCL14(11-74). Here we report that D6 efficiently binds both CCL14 and its truncated isoforms. Like other D6 ligands, the biologically active CCL14(9-74) induces adaptive up-regulation of D6 expression on the cell membrane and is rapidly and efficiently degraded. In contrast, the D6-mediated degradation of the biologically inactive isoforms CCL14(1-74) and CCL14(11-74) is very inefficient. Thus, D6 cooperates with CD26 in the negative regulation of CCL14 by the selective degradation of its biologically active isoform. Analysis of a panel of CC chemokines and their truncated isoforms revealed that D6-mediated chemokine degradation does not correlate with binding affinity. Conversely, degradation efficiency is positively correlated with D6 adaptive up-regulation. Sequence analysis indicated that a proline residue in position 2 of D6 ligands is dispensable for binding but crucial for D6 adaptive up-regulation and efficient degradation.

摘要

趋化因子诱饵受体D6通过选择性识别和降解大多数CCR1至CCR5激动剂配体来控制炎症反应。CCL14是一种稳态趋化因子,在血清中浓度较高,对CCR1具有弱激动剂活性。在炎症条件下,纤溶酶和尿激酶型纤溶酶原激活剂介导的8个氨基酸的截短产生了强效的CCR1/CCR3/CCR5同种型CCL14(9-74),其进一步被二肽基肽酶IV/CD26加工并失活,生成CCL14(11-74)。在此我们报告,D6能有效结合CCL14及其截短的同种型。与其他D6配体一样,具有生物活性的CCL14(9-74)诱导细胞膜上D6表达的适应性上调,并迅速且有效地被降解。相比之下,D6介导的无生物活性同种型CCL14(1-74)和CCL14(11-74)的降解效率非常低。因此,D6通过选择性降解其生物活性同种型与CD26协同对CCL14进行负调控。对一组CC趋化因子及其截短同种型的分析表明,D6介导的趋化因子降解与结合亲和力无关。相反,降解效率与D6适应性上调呈正相关。序列分析表明,D6配体第2位的脯氨酸残基对于结合并非必需,但对于D6适应性上调和有效降解至关重要。

相似文献

引用本文的文献

本文引用的文献

2
Chemokines and chemokine receptors: an overview.趋化因子与趋化因子受体:概述
Front Biosci (Landmark Ed). 2009 Jan 1;14(2):540-51. doi: 10.2741/3261.
5
Regulation of chemokine activity by posttranslational modification.通过翻译后修饰对趋化因子活性的调控。
Pharmacol Ther. 2008 Nov;120(2):197-217. doi: 10.1016/j.pharmthera.2008.08.006. Epub 2008 Aug 28.
10
Structural and functional characterization of CC chemokine CCL14.CC趋化因子CCL14的结构与功能特性
Biochemistry. 2007 Sep 4;46(35):10008-15. doi: 10.1021/bi700936w. Epub 2007 Aug 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验